-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/toolkits/sas-code.pdf
October 31, 2018 - immunological immuno
malignancy malign
mental health mh
metabolic metab
musculoskeletal musculo
neurological
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/toolkits/sas-code.pdf
October 31, 2018 - immunological immuno
malignancy malign
mental health mh
metabolic metab
musculoskeletal musculo
neurological
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/toolkits/sas-code.pdf
October 31, 2018 - immunological immuno
malignancy malign
mental health mh
metabolic metab
musculoskeletal musculo
neurological
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/toolkits/sas-code.pdf
October 31, 2018 - immunological immuno
malignancy malign
mental health mh
metabolic metab
musculoskeletal musculo
neurological
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/toolkits/sas-code.pdf
October 31, 2018 - immunological immuno
malignancy malign
mental health mh
metabolic metab
musculoskeletal musculo
neurological
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/research/findings/factsheets/translating/action3/ACTION%20-III-2019-Project-Summaries.pdf
January 01, 2019 - associated with a wide range of adverse consequences related to
physical and mental health (e.g., neurological
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/2024-01/fernandez-rosenman-report.pdf
January 01, 2024 - Neurological function at discharge defined as the Glasgow Coma Scale (GCS) at discharge.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/toolkits/sas-code.pdf
October 31, 2018 - immunological immuno
malignancy malign
mental health mh
metabolic metab
musculoskeletal musculo
neurological
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/elevated-blood-lead-levels-in-childhood-and-pregnancy-screening
April 16, 2019 - EPA, US Environmental Protection Agency; NEPSY, a developmental neuropsychological assessment; NESS, Neurological
-
effectivehealthcare.ahrq.gov/products/diabetes-behavior-programs/research-protocol
June 05, 2014 - average achieved HbA 1c was about 7 percent) significantly reduced the incidence of microvascular and neurological
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-236-maternal-fetal-child-outcomes-disposition-comments.pdf
April 15, 2021 - As noted in the body of the report (page
35), ”The Apgar score does not predict
long-term neurological
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2005.pdf
January 01, 2005 - 2005 AHRQ comorbidity measure: Metastatic cancer
CM_NEURO 2002-2005 AHRQ comorbidity measure: Other neurological
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2004.pdf
January 01, 2004 - 2004 AHRQ comorbidity measure: Metastatic cancer
CM_NEURO 2002-2004 AHRQ comorbidity measure: Other neurological
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2003_v7.pdf
January 01, 2003 - comorbidity measure: Metastatic
cancer
PA
CM_NEURO 2002-2003 AHRQ comorbidity measure: Other
neurological
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/factsheets/translating/action3/ACTION%20-III-2019-Project-Summaries.pdf
January 01, 2019 - associated with a wide range of adverse consequences related to
physical and mental health (e.g., neurological
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-236-maternal-fetal-child-outcomes-disposition-comments.pdf
April 15, 2021 - As noted in the body of the report (page
35), ”The Apgar score does not predict
long-term neurological
-
effectivehealthcare-admin.ahrq.gov/products/diabetes-behavior-programs/research-protocol
December 01, 2019 - average achieved HbA 1c was about 7 percent) significantly reduced the incidence of microvascular and neurological
-
www.ahrq.gov/sites/default/files/2024-01/fernandez-rosenman-report.pdf
January 01, 2024 - Neurological function at discharge defined as the Glasgow Coma Scale (GCS) at discharge.
-
digital.ahrq.gov/sites/default/files/docs/publication/p20hs015426-lozzio-final-report-2005.pdf
January 01, 2005 - hemostasis-thrombosis, cystic fibrosis, Down syndrome, familial
cancer and predictive testing [for neurological
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/toolkits/sas-code.pdf
October 31, 2018 - immunological immuno
malignancy malign
mental health mh
metabolic metab
musculoskeletal musculo
neurological